10x Genomics, Inc. Depreciation
10x Genomics, Inc. (TXG) reported Depreciation of $31.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-02-13
- 10x Genomics, Inc. depreciation for fiscal 2025 was $31.20M, a 7.96% decline from fiscal 2024.
- 10x Genomics, Inc. depreciation for fiscal 2024 was $33.90M, a 3.04% increase from fiscal 2023.
- 10x Genomics, Inc. depreciation for fiscal 2023 was $32.90M, a 44.30% increase from fiscal 2022.
- 10x Genomics, Inc. depreciation for fiscal 2022 was $22.80M, a 23.24% increase from fiscal 2021.
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $31.20M 10-K · filed 2026-02-13 |
| 2024-12-31 | $33.90M 10-K · filed 2026-02-13 |
| 2023-12-31 | $32.90M 10-K · filed 2026-02-13 |
| 2022-12-31 | $22.80M 10-K · filed 2025-02-13 |
| 2021-12-31 | $18.50M 10-K · filed 2024-02-15 |
| 2020-12-31 | $12.30M 10-K · filed 2023-02-16 |
| 2019-12-31 | $6.70M 10-K · filed 2022-02-18 |
| 2018-12-31 | $3.80M 10-K · filed 2021-02-26 |
| 2017-12-31 | $4.30M 10-K · filed 2020-02-27 |